{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T16:12:20Z","timestamp":1786378340457,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,11]]},"DOI":"10.7759\/cureus.85791","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T19:32:03Z","timestamp":1749670323000},"source":"Crossref","is-referenced-by-count":6,"title":["Role of Gastric Point-of-Care Ultrasound in Perioperative Management of Semaglutide"],"prefix":"10.7759","author":[{"given":"Mehana O","family":"Muranaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony H","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie  T","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Jau","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Felix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine L","family":"Carr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Wegovy\u2122 (semaglutide 2.4 mg), the first and only once-weekly GLP-1 therapy for weight management, approved in the US. (2021). Accessed. January 8, 2025: https:\/\/www.novonordisk.com\/news-and-media\/news-and-ir-materials\/news-details.html?id=62112."},{"key":"ref2","unstructured":"FDA Office of Women\u2019s Health. Women and Diabetes - Diabetes Medicine. (2024). Accessed. January 28, 2025: https:\/\/www.fda.gov\/consumers\/womens-health-topics\/women-and-diabetes-diabetes-medicines."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.721135","article-title":"GLP-1 receptor agonists: beyond their pancreatic effects","volume":"12","author":"Zhao X","year":"2021","unstructured":"Zhao X, Wang M, Wen Z, et al.. GLP-1 receptor agonists: beyond their pancreatic effects. Front Endocrinol (Lausanne). 2021, 12:5. 10.3389\/fendo.2021.721135","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref4","article-title":"Compare and contrast the glucagon-like peptide-1 receptor agonists (GLP1RAs)","author":"Latif W","year":"2024","unstructured":"Latif W, Lambrinos KJ, Rodriguez R. Compare and contrast the glucagon-like peptide-1 receptor agonists (GLP1RAs). StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2023.08.010","article-title":"The antidepressant effects of GLP-1 receptor agonists: a systematic review and meta-Analysis","volume":"32","author":"Chen X","year":"2024","unstructured":"Chen X, Zhao P, Wang W, Guo L, Pan Q. The antidepressant effects of GLP-1 receptor agonists: a systematic review and meta-Analysis. Am J Geriatr Psychiatry. 2024, 32:117-27. 10.1016\/j.jagp.2023.08.010","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102181","article-title":"Glucometabolic outcomes of GLP-1 receptor agonist-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysis","volume":"64","author":"Caruso I","year":"2023","unstructured":"Caruso I, Di Gioia L, Di Molfetta S, et al.. Glucometabolic outcomes of GLP-1 receptor agonist-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysis. EClinicalMedicine. 2023, 64:102181. 10.1016\/j.eclinm.2023.102181","journal-title":"EClinicalMedicine"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0278685","article-title":"Effect of glucagon-like peptide-1 receptor agonists on glycemic control, and weight reduction in adults: a multivariate meta-analysis","volume":"18","author":"Yeh TL","year":"2023","unstructured":"Yeh TL, Tsai MC, Tsai WH, Tu YK, Chien KL. Effect of glucagon-like peptide-1 receptor agonists on glycemic control, and weight reduction in adults: a multivariate meta-analysis. PLoS One. 2023, 18:e0278685. 10.1371\/journal.pone.0278685","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.obmed.2022.100456","article-title":"Effects of GLP-1 agonists on proportion of weight loss in obesity with or without diabetes: systematic review and meta-analysis","volume":"35","author":"Vosoughi K","year":"2022","unstructured":"Vosoughi K, Roghani RS, Camilleri M. Effects of GLP-1 agonists on proportion of weight loss in obesity with or without diabetes: systematic review and meta-analysis. Obes Med. 2022, 35:100456. 10.1016\/j.obmed.2022.100456","journal-title":"Obes Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01474-z","article-title":"The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs","volume":"21","author":"Giugliano D","year":"2022","unstructured":"Giugliano D, Longo M, Signoriello S, Maiorino MI, Solerte B, Chiodini P, Esposito K. The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs. Cardiovasc Diabetol. 2022, 21:42. 10.1186\/s12933-022-01474-z","journal-title":"Cardiovasc Diabetol"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar N","year":"2021","unstructured":"Sattar N, Lee MMY, Kristensen SL, et al.. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. Lancet Diabetes Endocrinol. 2021, 9:653-62.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.32610","article-title":"Efficacy of semaglutide in treating obesity: a systematic review of randomized controlled trials (RCTs)","volume":"14","author":"Anam M","year":"2022","unstructured":"Anam M, Maharjan S, Amjad Z, et al.. Efficacy of semaglutide in treating obesity: a systematic review of randomized controlled trials (RCTs). Cureus. 2022, 14:e32610. 10.7759\/cureus.32610","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-020-01106-4","article-title":"Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials","volume":"19","author":"Husain M","year":"2020","unstructured":"Husain M, Bain SC, Holst AG, Mark T, Rasmussen S, Lingvay I. Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials. Cardiovasc Diabetol. 2020, 19:156. 10.1186\/s12933-020-01106-4","journal-title":"Cardiovasc Diabetol"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(17)30013-X","article-title":"Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial","volume":"5","author":"Sorli C","year":"2017","unstructured":"Sorli C, Harashima SI, Tsoukas GM, et al.. Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial. Lancet Diabetes Endocrinol. 2017, 5:251-60.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(19)30192-5","article-title":"Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial","volume":"7","author":"Mosenzon O","year":"2019","unstructured":"Mosenzon O, Blicher TM, Rosenlund S, et al.. Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial. Lancet Diabetes Endocrinol. 2019, 7:515-27.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod MN","year":"2023","unstructured":"Kosiborod MN, Abildstr\u00f8m SZ, Borlaug BA, et al.. Semaglutide in patients with heart failure with preserved ejection fraction and obesity. N Engl J Med. 2023, 389:1069-84. 10.1056\/NEJMoa2306963","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12593","article-title":"Gastrointestinal actions of glucagon-like peptide-1-based therapies: glycaemic control beyond the pancreas","volume":"18","author":"Smits MM","year":"2016","unstructured":"Smits MM, Tonneijck L, Muskiet MH, Kramer MH, Cahen DL, van Raalte DH. Gastrointestinal actions of glucagon-like peptide-1-based therapies: glycaemic control beyond the pancreas. Diabetes Obes Metab. 2016, 18:224-35. 10.1111\/dom.12593","journal-title":"Diabetes Obes Metab"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2023.111091","article-title":"Relationship between perioperative semaglutide use and residual gastric content: a retrospective analysis of patients undergoing elective upper endoscopy","volume":"87","author":"Silveira SQ","year":"2023","unstructured":"Silveira SQ, da Silva LM, de Campos Vieira Abib A, et al.. Relationship between perioperative semaglutide use and residual gastric content: a retrospective analysis of patients undergoing elective upper endoscopy. J Clin Anesth. 2023, 87:111091. 10.1016\/j.jclinane.2023.111091","journal-title":"J Clin Anesth"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.14005","article-title":"Association of glucagon-like peptide-1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy","volume":"14","author":"Kobori T","year":"2023","unstructured":"Kobori T, Onishi Y, Yoshida Y, et al.. Association of glucagon-like peptide-1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy. J Diabetes Investig. 2023, 14:767-73. 10.1111\/jdi.14005","journal-title":"J Diabetes Investig"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.42153","article-title":"Anesthesia considerations for a patient on semaglutide and delayed gastric emptying","volume":"15","author":"Fujino E","year":"2023","unstructured":"Fujino E, Cobb KW, Schoenherr J, Gouker L, Lund E. Anesthesia considerations for a patient on semaglutide and delayed gastric emptying. Cureus. 2023, 15:e42153. 10.7759\/cureus.42153","journal-title":"Cureus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-023-02550-y","article-title":"Anesthesia and glucagon-like peptide-1 receptor agonists: proceed with caution!","volume":"70","author":"Jones PM","year":"2023","unstructured":"Jones PM, Hobai IA, Murphy PM. Anesthesia and glucagon-like peptide-1 receptor agonists: proceed with caution!. Can J Anaesth. 2023, 70:1281-6. 10.1007\/s12630-023-02550-y","journal-title":"Can J Anaesth"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-023-02521-3","article-title":"Regurgitation under anesthesia in a fasted patient prescribed semaglutide for weight loss: a case report","volume":"70","author":"Gulak MA","year":"2023","unstructured":"Gulak MA, Murphy P. Regurgitation under anesthesia in a fasted patient prescribed semaglutide for weight loss: a case report. Can J Anaesth. 2023, 70:1397-400. 10.1007\/s12630-023-02521-3","journal-title":"Can J Anaesth"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000006810","article-title":"Anesthetic considerations in adult patients on glucagon-like peptide-1 receptor agonists: gastrointestinal focus","volume":"138","author":"Joshi GP","year":"2024","unstructured":"Joshi GP. Anesthetic considerations in adult patients on glucagon-like peptide-1 receptor agonists: gastrointestinal focus. Anesth Analg. 2024, 138:216-20. 10.1213\/ANE.0000000000006810","journal-title":"Anesth Analg"},{"key":"ref23","article-title":"American Society of Anesthesiologists consensus-based guidance on preoperative management of patients (adults and children) on glucagon-like peptide-1 (GLP-1) receptor agonists","author":"Joshi GP","year":"2023","unstructured":"Joshi GP, Abdelmalak BB, Weigel WA, et al.. American Society of Anesthesiologists consensus-based guidance on preoperative management of patients (adults and children) on glucagon-like peptide-1 (GLP-1) receptor agonists. American Society of Anesthesiologists, Schaumberg, IL; 2023."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.11.002","article-title":"AGA rapid clinical practice update on the management of patients taking GLP-1 receptor agonists prior to endoscopy: communication","volume":"22","author":"Hashash JG","year":"2024","unstructured":"Hashash JG, Thompson CC, Wang AY. AGA rapid clinical practice update on the management of patients taking GLP-1 receptor agonists prior to endoscopy: communication. Clin Gastroenterol Hepatol. 2024, 22:705-7. 10.1016\/j.cgh.2023.11.002","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S016","article-title":"Diabetes care in the hospital: standards of care in diabetes\u20142025","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee. Diabetes care in the hospital: standards of care in diabetes\u20142025. Diabetes Care. 2025, 48:S321-34. 10.2337\/dc25-S016","journal-title":"Diabetes Care"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000005231","article-title":"Preprocedure care of patients on glucagon-like peptide-1 receptor agonists: a multisociety clinical practice guidance","volume":"141","author":"Joshi GP","year":"2024","unstructured":"Joshi GP, LaMasters T, Kindel TL. Preprocedure care of patients on glucagon-like peptide-1 receptor agonists: a multisociety clinical practice guidance. Anesthesiology. 2024, 141:1208-9. 10.1097\/ALN.0000000000005231","journal-title":"Anesthesiology"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-017-1031-9","article-title":"Point-of-care gastric ultrasound and aspiration risk assessment: a narrative review","volume":"65","author":"Perlas A","year":"2018","unstructured":"Perlas A, Arzola C, Van de Putte P. Point-of-care gastric ultrasound and aspiration risk assessment: a narrative review. Can J Anaesth. 2018, 65:437-48. 10.1007\/s12630-017-1031-9","journal-title":"Can J Anaesth"},{"key":"ref28","article-title":"Gastric ultrasound","author":"Flynn DN","year":"2025","unstructured":"Flynn DN, Doyal A, Schoenherr JW. Gastric ultrasound. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000001452","article-title":"Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures","volume":"126","author":"American Society of Anesthesiologists","year":"2017","unstructured":"American Society of Anesthesiologists. Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures. Anesthesiology. 2017, 126:376-93. 10.1097\/ALN.0000000000001452","journal-title":"Anesthesiology"},{"key":"ref30","unstructured":"Gastric ultrasound. a point-of-care tool for aspiration risk assessment. (2020). Accessed: January 8, 2024: https:\/\/www.gastricultrasound.org\/swfiles\/files\/GastricUlraSound_Flowchart2020.pdf.."},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2024.116119","article-title":"A systematic review of the use of GLP-1 receptor agonists in surgery","volume":"240","author":"Ihnat JM","year":"2025","unstructured":"Ihnat JM, De Baun H, Carrillo G, Dony A, Mukherjee TJ, Ayyala HS. A systematic review of the use of GLP-1 receptor agonists in surgery. Am J Surg. 2025, 240:116119. 10.1016\/j.amjsurg.2024.116119","journal-title":"Am J Surg"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000003831","article-title":"Pulmonary aspiration of gastric contents: a closed claims analysis","volume":"135","author":"Warner MA","year":"2021","unstructured":"Warner MA, Meyerhoff KL, Warner ME, Posner KL, Stephens L, Domino KB. Pulmonary aspiration of gastric contents: a closed claims analysis. Anesthesiology. 2021, 135:284-91. 10.1097\/ALN.0000000000003831","journal-title":"Anesthesiology"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2024.08.039","article-title":"Evaluation of gastric content in fasting patient during semaglutide use: an observational study","volume":"21","author":"Queiroz VN","year":"2025","unstructured":"Queiroz VN, Falsarella PM, Chaves RC, et al.. Evaluation of gastric content in fasting patient during semaglutide use: an observational study. Surg Obes Relat Dis. 2025, 21:146-51. 10.1016\/j.soard.2024.08.039","journal-title":"Surg Obes Relat Dis"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.5301\/urologia.5000050","article-title":"The cancelling of elective surgical operations causes emotional trauma and a lack of confidence: study from a urological department","volume":"81","author":"Dell'Atti L","year":"2014","unstructured":"Dell'Atti L. The cancelling of elective surgical operations causes emotional trauma and a lack of confidence: study from a urological department. Urologia. 2014, 81:242-5. 10.5301\/urologia.5000050","journal-title":"Urologia"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1503\/cjs.008119","article-title":"Cancellation of elective surgery: rates, reasons and effect on patient satisfaction","volume":"64","author":"Koh WX","year":"2021","unstructured":"Koh WX, Phelan R, Hopman WM, Engen D. Cancellation of elective surgery: rates, reasons and effect on patient satisfaction. Can J Surg. 2021, 64:E155-61. 10.1503\/cjs.008119","journal-title":"Can J Surg"},{"key":"ref36","unstructured":"Anesthesiology Supplemental Guide. (2020). Accessed. January 8, 2025: https:\/\/www.acgme.org\/globalassets\/pdfs\/milestones\/anesthesiologysupplementalguide.pdf."},{"key":"ref37","unstructured":"APPLIED Exam Objective Structured Clinical Examination (OSCE) Content Outline. (2022). Accessed. January 8, 2025: https:\/\/www.theaba.org\/wp-content\/uploads\/pdfs\/OSCE_Content_Outline.pdf."},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1814-y","article-title":"Ultrasound-guided central venous catheter placement: a structured review and recommendations for clinical practice","volume":"21","author":"Saugel B","year":"2017","unstructured":"Saugel B, Scheeren TW, Teboul JL. Ultrasound-guided central venous catheter placement: a structured review and recommendations for clinical practice. Crit Care. 2017, 21:225. 10.1186\/s13054-017-1814-y","journal-title":"Crit Care"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-013-9974-y","article-title":"Anesthesiologists' learning curves for bedside qualitative ultrasound assessment of gastric content: a cohort study","volume":"60","author":"Arzola C","year":"2013","unstructured":"Arzola C, Carvalho JC, Cubillos J, Ye XY, Perlas A. Anesthesiologists' learning curves for bedside qualitative ultrasound assessment of gastric content: a cohort study. Can J Anaesth. 2013, 60:771-9. 10.1007\/s12630-013-9974-y","journal-title":"Can J Anaesth"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.462","article-title":"Glucagon-like peptide agonists: a prospective review","volume":"7","author":"Mariam Z","year":"2024","unstructured":"Mariam Z, Niazi SK. Glucagon-like peptide agonists: a prospective review. Endocrinol Diabetes Metab. 2024, 7:e462. 10.1002\/edm2.462","journal-title":"Endocrinol Diabetes Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/370248-role-of-gastric-point-of-care-ultrasound-in-perioperative-management-of-semaglutide","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T19:32:06Z","timestamp":1749670326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/370248-role-of-gastric-point-of-care-ultrasound-in-perioperative-management-of-semaglutide"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":40,"URL":"https:\/\/doi.org\/10.7759\/cureus.85791","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,11]]}}}